ArticleJACC. Case reports2025
Bailout Percutaneous Balloon Mitral Valvuloplasty for Bioprosthetic Mitral Valve Stenosis as a Bridge to Surgery.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPercutaneous mitral valvuloplasty is the treatment of choice for clinically significant native mitral valve stenosis, however there have been limited reports of successful balloon valvuloplasty for bioprosthetic mitral valve stenosis. CASE SUMMARY: A 44-year-old woman presented with decompensated heart failure and severe bioprosthetic mitral valve stenosis. She developed cardiogenic shock and was deemed at prohibitive operative risk. Urgent percutaneous balloon valvuloplasty was performed, resulting in hemodynamic stabilization and improvement of mitral valve area to 1.6 cm DISCUSSION: A literature search identified 16 cases of balloon valvuloplasty of bioprosthesis degeneration in the mitral position; nearly all patients, as in our case, experienced symptom improvement. TAKE-HOME MESSAGE: Percutaneous balloon valvuloplasty for bioprosthetic mitral valve degeneration and stenosis can be a valuable salvage strategy in highly selected patients with severe hemodynamic compromise as a bridge to definitive surgical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.